Real-time enrollment status for this non-small cell lung cancer clinical trial
Current Status
Suspended
Checked: March 2, 2026 at 7:17 AM UTC
| NCT Number | NCT06732401 |
| Recruiting Status | Suspended |
| Condition | Non-Small Cell Lung Cancer |
| Phase | Clinical Trial |
| Target Enrollment | 630 participants |
| Active Locations | 86 sites in the US |
| Sponsor | National Cancer Institute (NCI) |
| Last Updated on CT.gov | February 27, 2026 (3 days ago) |
As of March 2, 2026: Clinical trial NCT06732401 is currently suspended participants. This clinical trial study for non-small cell lung cancer is not currently accepting new participants at 86 locations across the United States. The study is sponsored by National Cancer Institute (NCI). This status information is automatically verified from the official ClinicalTrials.gov registry.
No, NCT06732401 is currently suspended. The study may resume recruiting in the future.
This trial is recruiting at 86 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06732401 was last updated 3 days ago (February 27, 2026). HelloStudys verifies this status automatically.